Edition:
India

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

0.93USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,205
52-wk High
$5.07
52-wk Low
$0.90

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.14 December 11 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 3 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3 7.34 11.82 4.00 5.40
Quarter Ending Mar-19 1 6.20 6.20 6.20 5.01
Year Ending Dec-18 3 41.43 46.06 38.24 23.87
Year Ending Dec-19 3 33.95 42.30 25.00 31.58
Earnings (per share)
Quarter Ending Dec-18 2 -0.14 -0.07 -0.22 -0.37
Year Ending Dec-18 3 -0.49 -0.16 -0.99 -1.44
Year Ending Dec-19 3 -0.95 -0.41 -1.53 -0.90

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 7.38 19.52 12.14 164.59
Quarter Ending Jun-18 7.06 6.87 0.19 2.69
Quarter Ending Mar-18 6.76 7.85 1.09 16.11
Quarter Ending Dec-17 5.20 20.64 15.44 296.82
Quarter Ending Sep-17 5.12 5.11 0.02 0.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7.34 7.34 7.34 7.16 5.40
Quarter Ending Mar-19 6.20 6.20 6.20 6.20 5.01
Year Ending Dec-18 41.43 41.57 41.57 29.24 23.87
Year Ending Dec-19 33.95 33.88 33.88 25.69 31.58

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 1 0 1 0
Earnings